Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

INMD

Inmode Ltd

Feb 12 • 04:00PM ET

18.89

Dollar change +0.31
Percentage change 1.67	%

Healthcare • Medical Devices • Israel • NASD

Peers: ALGN IRTC CUTR PODD NVCR HAE CERS VCEL MDXG CLGN

| Held by: IWM IWN IEFA VTWO SCZ IZRL IXUS PSC IWO SMLF

Scroll to Statements

Index	RUT	P/E	8.08	EPS (ttm)	2.34	Insider Own	13.32%	Shs Outstand	69.56M	Perf Week	5.18%
Market Cap	1.31B	Forward P/E	8.86	EPS next Y	2.13	Insider Trans	0.00%	Shs Float	60.29M	Perf Month	18.28%
Income	181.28M	PEG	0.84	EPS next Q	0.38	Inst Own	63.28%	Short Float	10.04%	Perf Quarter	-2.68%
Sales	394.82M	P/S	3.33	EPS this Y	10.33%	Inst Trans	-13.90%	Short Ratio	6.53	Perf Half Y	20.32%
Book/sh	10.12	P/B	1.87	EPS next Y	9.86%	ROA	21.99%	Short Interest	6.05M	Perf Year	-27.23%
Cash/sh	8.58	P/C	2.20	EPS next 5Y	9.62%	ROE	24.31%	52W Range	14.87 - 26.80	Perf YTD	13.11%
Dividend Est.	-	P/FCF	9.96	EPS past 5Y	16.55%	ROI	25.56%	52W High	-29.51%	Beta	2.10
Dividend TTM	-	Quick Ratio	9.16	Sales past 5Y	24.18%	Gross Margin	80.31%	52W Low	27.03%	ATR (14)	0.58
Dividend Ex-Date	-	Current Ratio	10.23	EPS Y/Y TTM	0.38%	Oper. Margin	28.50%	RSI (14)	67.98	Volatility	3.17% 2.87%
Employees	599	Debt/Eq	0.01	Sales Y/Y TTM	-19.76%	Profit Margin	45.91%	Recom	2.43	Target Price	21.33
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	312.63%	Payout	0.00%	Rel Volume	1.18	Prev Close	18.58
Sales Surprise	-10.33%	EPS Surprise	-20.42%	Sales Q/Q	21.88%	Earnings	Feb 04 BMO	Avg Volume	927.48K	Price	18.89
SMA20	8.23%	SMA50	7.71%	SMA200	7.84%	Trades		Volume	1,091,224	Change	1.67%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-17-24	Initiated	BTIG Research	Buy	$25
Jul-23-24	Downgrade	Jefferies	Buy → Hold	$21 → $19
Nov-03-23	Downgrade	UBS	Buy → Neutral	$52 → $24
Oct-13-23	Downgrade	Canaccord Genuity	Buy → Hold	$55 → $22
Mar-29-23	Initiated	UBS	Buy	$40
Feb-17-23	Downgrade	Needham	Buy → Hold
Dec-21-22	Initiated	Barclays	Overweight	$44
Oct-12-22	Initiated	Jefferies	Buy	$40
May-25-21	Initiated	Barclays	Overweight	$92
May-18-21	Initiated	Needham	Buy	$94
Sep-03-19	Initiated	UBS	Buy	$28
Sep-03-19	Initiated	Robert W. Baird	Outperform	$27
Sep-03-19	Initiated	Canaccord Genuity	Buy	$30
Sep-03-19	Initiated	Barclays	Overweight	$27

Show Previous Ratings

Feb-06-25 06:00PM	InMode (INMD) Q4 2024 Earnings Call Transcript (Motley Fool)
Feb-05-25 07:10AM	InMode Ltd (INMD) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
02:08AM	InMode Ltd (INMD) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... (GuruFocus.com)
Feb-04-25 07:16AM	InMode: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program (PR Newswire)
08:30AM	Loading…
Feb-03-25 08:30AM	InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference (PR Newswire)
Jan-29-25 09:48AM	Do Options Traders Know Something About InMode (INMD) Stock We Don't? (Zacks)
Jan-16-25 07:00AM	InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced (PR Newswire)
Jan-15-25 08:05AM	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback (PR Newswire)
Jan-08-25 07:00AM	InMode to Report Fourth Quarter and Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M (PR Newswire) -7.99%
07:00AM	InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M (PR Newswire)
Dec-10-24 10:53PM	Why Is InMode Ltd. (INMD) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey)
Nov-06-24 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire) +7.65%
Oct-31-24 07:29AM	InMode Sees Revenue Growth Amidst Challenges in Q3 2024 (TipRanks)
03:07AM	InMode Ltd (INMD) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com)
01:25AM	Loading…
01:25AM	Q3 2024 Inmode Ltd Earnings Call (Thomson Reuters StreetEvents)
Oct-30-24 03:45PM	InMode (INMD) Q3 2024 Earnings Call Transcript (Motley Fool)
08:10AM	InMode (INMD) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:07AM	InMode: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024) (PR Newswire)
Oct-29-24 09:11AM	What To Expect From InMode Ltd (INMD) Q3 2024 Earnings (GuruFocus.com)
Oct-24-24 07:03AM	InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories (PR Newswire)
Oct-23-24 10:01AM	Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline (Zacks)
Oct-14-24 09:40AM	Is InMode (INMD) a Great Value Stock Right Now? (Zacks)
Oct-13-24 05:25PM	InMode price target lowered to $27 from $29 at Barclays (TipRanks)
Oct-10-24 07:00AM	InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 (PR Newswire) +7.38%
Oct-09-24 03:42PM	InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations (GuruFocus.com)
Oct-02-24 07:28AM	InMode Restructures Amidst Global Expansion (TipRanks)
Oct-01-24 07:00AM	InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy (PR Newswire) -8.55%
Sep-26-24 09:40AM	Should Value Investors Buy InMode (INMD) Stock? (Zacks)
05:34AM	Loading…
Sep-23-24 05:34AM	InMode (INMD): Among the Worst Middle East and Africa Stocks to Buy Now (Insider Monkey) -5.80%
Sep-10-24 09:40AM	Are Investors Undervaluing InMode (INMD) Right Now? (Zacks) +8.83%
07:00AM	InMode Announces Share Repurchase Program of Up to 7.68 Million Shares (PR Newswire)
Sep-04-24 08:30AM	InMode to Present at 2024 Baird Global Healthcare Conference (PR Newswire)
Sep-01-24 11:27PM	InMode (INMD): The Best Middle East and Africa Stocks to Buy According to Analysts? (Insider Monkey)
Aug-14-24 11:05AM	InMode Ltd. (INMD): Challenges and Insights in the Beauty Industry (Insider Monkey)
Aug-09-24 06:46AM	Why Are Analysts Bullish on InMode Ltd. (INMD) Right Now? (Insider Monkey)
Aug-06-24 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire)
Aug-01-24 10:30PM	InMode (INMD) Q2 2024 Earnings Call Transcript (Motley Fool) -8.55%
08:15AM	InMode (INMD) Q2 Earnings and Revenues Top Estimates (Zacks)
07:14AM	InMode: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M (PR Newswire)
Jul-31-24 08:03AM	InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform (PR Newswire)
Jul-25-24 10:02AM	Analysts Estimate InMode (INMD) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:15AM	DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer (PR Newswire)
Jul-17-24 08:03AM	Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling (PR Newswire)
Jul-11-24 08:30AM	InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024 (PR Newswire)
Jul-01-24 06:00AM	3 MedTech Stocks to Buy for Healthy Gains (InvestorPlace)
May-16-24 08:00AM	InMode to Present at Jefferies Healthcare Conference (PR Newswire)
May-08-24 08:03AM	InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand (PR Newswire)
May-03-24 12:12PM	InMode Ltd. (NASDAQ:INMD) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:41AM	UBS Adjusts Price Target on InMode to $20 From $26, Maintains Neutral Rating (MT Newswires)
May-02-24 07:15PM	InMode (INMD) Q1 2024 Earnings Call Transcript (Motley Fool)
01:31PM	InMode Shares Rise; Q1 Non-GAAP Earnings, Revenue Fall; 2024 Guidance Cut (MT Newswires)
11:55AM	INMD Stock Earnings: InMode Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:30AM	InMode (INMD) Q1 Earnings and Revenues Beat Estimates (Zacks)
08:30AM	InMode: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M; (PR Newswire)
Apr-25-24 10:01AM	Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline (Zacks)
Apr-15-24 07:00AM	InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL (PR Newswire)
05:45AM	Shareholders of InMode Ltd. Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD (PR Newswire)
Apr-10-24 05:45AM	InMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - INMD (PR Newswire)
Apr-09-24 07:00AM	InMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024 (PR Newswire) -6.87%
Apr-03-24 06:00PM	InMode (INMD) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
08:00AM	InMode to Present at Upcoming Investor Conferences and Events (PR Newswire)
Apr-01-24 09:30AM	Is InMode (INMD) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
09:00AM	InMode Ltd. (INMD) is Attracting Investor Attention: Here is What You Should Know (Zacks)
05:45AM	InMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD (PR Newswire)
Mar-28-24 06:00PM	Why InMode (INMD) Outpaced the Stock Market Today (Zacks)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-21-24 06:00PM	InMode (INMD) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Mar-19-24 09:00AM	InMode Ltd. (INMD) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-15-24 05:50PM	Why InMode (INMD) Dipped More Than Broader Market Today (Zacks)
09:30AM	Brokers Suggest Investing in InMode (INMD): Read This Before Placing a Bet (Zacks)
Mar-13-24 11:45AM	SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InMode (PR Newswire)
06:09AM	Should You Hold Inmode Ltd. (INMD)? (Insider Monkey)
Mar-12-24 07:24AM	Should You Hold InMode Ltd. (INMD)? (Insider Monkey)
05:45AM	InMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD (PR Newswire)
Mar-04-24 08:30AM	InMode to Present at March Investor Conferences and Events (PR Newswire)
Feb-28-24 09:47AM	Cathie Wood Was Buying These 11 Stocks for 2024 (Insider Monkey)
Feb-23-24 01:00PM	INMODE SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In InMode To Contact Him Directly To Discuss Their Options (GlobeNewswire)
09:30AM	Is It Worth Investing in InMode (INMD) Based on Wall Street's Bullish Views? (Zacks)
Feb-22-24 07:12PM	InMode Ltd. (INMD) Sued, Stock Crashes After Report of Severe Discounting- Hagens Berman (GlobeNewswire)
Feb-14-24 09:36AM	InMode Ltd. (NASDAQ:INMD) Q4 2023 Earnings Call Transcript (Insider Monkey)
02:29AM	Q4 2023 Inmode Ltd Earnings Call (Thomson Reuters StreetEvents)
Feb-13-24 06:15PM	InMode (INMD) Q4 2023 Earnings Call Transcript (Motley Fool) -10.65%
02:06PM	Former Highflier InMode Crumbles As Interest Rates, Macro Weigh On Aesthetics Procedures (Investor's Business Daily)
08:02AM	InMode Q4 Results Top Estimates; Guides FY24 Adj. EPS Above Estimates (RTT News)
07:21AM	InMode: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M (PR Newswire)
Feb-12-24 05:37AM	Forget the "Magnificent Seven": These 2 Under-the-Radar Growth Stocks Are Better Bargains (Motley Fool)
Feb-05-24 05:50PM	Here's Why InMode (INMD) Fell More Than Broader Market (Zacks) +5.40%
Jan-30-24 05:50PM	InMode (INMD) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Jan-27-24 06:57PM	InMode Stock (NASDAQ:INMD): 2 Catalysts That Can Send Shares Skyrocketing (TipRanks)
Jan-24-24 05:50PM	InMode (INMD) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Jan-23-24 06:00PM	InMode (INMD) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-17-24 06:00PM	InMode (INMD) Rises As Market Takes a Dip: Key Facts (Zacks)
Jan-16-24 07:00AM	InMode to Report Fourth Quarter & Full Year 2023 Financial Results and Hold Conference Call on Feb. 13, 2024, Expects Q4 Revenue Between $126.0M-$126.5M (PR Newswire)
Jan-08-24 05:50PM	InMode (INMD) Outperforms Broader Market: What You Need to Know (Zacks)
Jan-07-24 08:30AM	3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond (Motley Fool)

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INMD

Inmode Ltd

Upgrade your FINVIZ experience